USPH Q3 Net Income Nearly Doubles on Revenue Growth, Clinic Expansion

Ticker: USPH · Form: 10-Q · Filed: Nov 7, 2025 · CIK: 885978

Sentiment: bullish

Topics: Healthcare Services, Physical Therapy, Earnings Growth, Clinic Expansion, Acquisitions, Q3 Earnings, Financial Performance

Related Tickers: USPH, PT, LH

TL;DR

**USPH is crushing it with nearly double the net income, making it a strong buy in the healthcare services space.**

AI Summary

U.S. Physical Therapy, Inc. (USPH) demonstrated robust financial growth for the three and nine months ended September 30, 2025. Net revenue increased by 17.3% to $197.1 million for the three months ended September 30, 2025, compared to $168.0 million in the prior year, and by 17.8% to $578.3 million for the nine months, up from $490.9 million. Net income attributable to USPH shareholders surged by 98.2% to $13.1 million ($0.48 per share) for the three-month period, from $6.6 million ($0.39 per share) in 2024, and by 59.7% to $35.4 million ($1.85 per share) for the nine-month period, from $22.2 million ($1.32 per share). This significant improvement was partly driven by a substantial gain on the change in fair value of contingent earn-out consideration, which swung from a $1.9 million loss in Q3 2024 to a $5.9 million gain in Q3 2025. The company expanded its operations, adding 18 clinics and closing seven, bringing the total to 779 owned and/or managed clinics as of September 30, 2025, up from 700 a year prior. Cash and cash equivalents decreased by $10.3 million to $31.1 million from $41.4 million at December 31, 2024, primarily due to increased investing activities, including $15.2 million for business acquisitions.

Why It Matters

This strong performance by U.S. Physical Therapy, Inc. signals robust demand in the healthcare services sector, particularly for physical and occupational therapy. For investors, the nearly doubled net income and significant EPS growth to $0.48 per share demonstrate effective operational leverage and strategic acquisitions, potentially making USPH an attractive growth stock. Employees benefit from the company's expansion, with 79 new clinics added year-over-year, suggesting job stability and growth opportunities. Customers gain from increased access to physical therapy services, enhancing community health outcomes. Competitively, USPH's aggressive clinic expansion and acquisition strategy, including a 50% interest in a 50-clinic acquisition in October 2024, positions it to gain market share against smaller, independent practices and other regional chains.

Risk Assessment

Risk Level: medium — While USPH shows strong growth, its cash and cash equivalents decreased by $10.3 million to $31.1 million from December 31, 2024, and net cash provided by operating activities declined from $55.5 million in 2024 to $50.1 million in 2025 for the nine-month period. Additionally, the company's revolving facility balance increased significantly from $11.0 million at December 31, 2024, to $26.5 million at September 30, 2025, indicating increased reliance on debt for expansion and operations.

Analyst Insight

Investors should consider USPH for its strong growth trajectory and increased profitability, but monitor its cash flow and debt levels closely. The company's aggressive acquisition strategy is paying off in revenue and net income, but the reliance on the revolving facility warrants attention. A 'hold' rating is appropriate for existing investors, while new investors might consider a small position, watching for sustained positive operating cash flow trends.

Financial Highlights

debt To Equity
0.82
revenue
$197.1M
total Assets
$1,196.3M
total Debt
$171.2M
net Income
$13.1M
eps
$0.48
cash Position
$31.1M
revenue Growth
+17.3%

Key Numbers

Key Players & Entities

FAQ

What were U.S. Physical Therapy, Inc.'s net revenues for the third quarter of 2025?

U.S. Physical Therapy, Inc.'s net revenues for the three months ended September 30, 2025, were $197.1 million, an increase from $168.0 million for the same period in 2024.

How did U.S. Physical Therapy, Inc.'s net income attributable to shareholders change in Q3 2025?

Net income attributable to USPH shareholders for the three months ended September 30, 2025, increased by 98.2% to $13.1 million, up from $6.6 million in the third quarter of 2024.

What was the basic earnings per share for U.S. Physical Therapy, Inc. in the third quarter of 2025?

The basic and diluted earnings per share attributable to USPH shareholders for the three months ended September 30, 2025, was $0.48, an increase from $0.39 in the prior year's third quarter.

How many clinics did U.S. Physical Therapy, Inc. operate as of September 30, 2025?

As of September 30, 2025, U.S. Physical Therapy, Inc. operated 779 owned and/or managed clinics, an increase from 700 clinics as of September 30, 2024.

What was the impact of contingent earn-out consideration on U.S. Physical Therapy, Inc.'s operating income?

The gain on change in fair value of contingent earn-out consideration was $5.9 million for the three months ended September 30, 2025, a significant positive swing from a $1.9 million loss in the same period of 2024.

What are the key risks associated with U.S. Physical Therapy, Inc.'s financial position?

Key risks include a decrease in cash and cash equivalents by $10.3 million to $31.1 million and an increase in the revolving facility balance to $26.5 million, indicating higher debt reliance and potentially tighter liquidity.

How much did U.S. Physical Therapy, Inc. spend on business acquisitions in the nine months ended September 30, 2025?

U.S. Physical Therapy, Inc. spent $15.2 million on the purchase of interests in businesses, net of cash acquired, during the nine months ended September 30, 2025.

What is U.S. Physical Therapy, Inc.'s strategic outlook based on this filing?

The company's strategic outlook appears bullish, driven by aggressive clinic expansion, including 18 new clinics in Q3 2025, and successful acquisitions contributing to significant revenue and net income growth.

Did U.S. Physical Therapy, Inc. declare dividends in Q3 2025?

Yes, U.S. Physical Therapy, Inc. declared dividends of $0.45 per common share for the three months ended September 30, 2025, an increase from $0.44 in the prior year.

What is the primary business of U.S. Physical Therapy, Inc.?

U.S. Physical Therapy, Inc. primarily operates physical, speech, and occupational therapy clinics, and also provides industrial injury prevention services (IIP) directly to employers.

Risk Factors

Industry Context

The physical therapy industry is characterized by a growing demand for outpatient rehabilitation services driven by an aging population, increased awareness of non-surgical treatment options, and favorable insurance coverage for physical therapy. The sector is competitive, with a mix of independent clinics, hospital-affiliated centers, and large national providers like USPH. Consolidation is an ongoing trend as larger players acquire smaller practices to achieve economies of scale and expand geographic reach.

Regulatory Implications

As a healthcare provider, USPH operates within a heavily regulated environment. Compliance with Medicare and Medicaid regulations, HIPAA privacy rules, and state licensing requirements is critical. Changes in healthcare reform, reimbursement rates from government and private payers, and fraud and abuse laws can significantly impact the company's financial performance and operational strategies.

What Investors Should Do

  1. Monitor acquisition strategy and integration success.
  2. Analyze the impact of contingent earn-out adjustments.
  3. Evaluate debt levels and revolving credit facility usage.
  4. Assess operational efficiency and same-store growth.

Key Dates

Glossary

Contingent Earn-out Consideration
An amount of future payment to sellers of a business that is contingent upon the acquired business achieving certain performance targets after the acquisition. (Changes in the fair value of these contingent payments significantly impacted USPH's net income in the current quarter, swinging from a loss to a gain.)
Operating Lease Right-of-Use Assets
Assets recognized under accounting standards for leases, representing the lessee's right to use an underlying asset for the lease term. (These represent a significant portion of the company's assets ($139.9M), reflecting the leased nature of many of its clinic locations.)
Non-controlling Interest
The portion of equity in a subsidiary that is not attributable to the parent company. Redeemable non-controlling interest represents equity that may be redeemed by the holder. (USPH has significant redeemable non-controlling interests ($277.7M), indicating partial ownership of its subsidiaries by other parties, which impacts consolidated equity and earnings per share calculations.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (USPH has substantial goodwill ($690.4M), primarily from past acquisitions, indicating a strategy of growth through M&A.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, U.S. Physical Therapy, Inc. (USPH) has demonstrated strong top-line growth, with net revenue increasing by 17.3% in Q3 2025. Net income saw a substantial surge of 98.2%, significantly boosted by a favorable swing in the fair value of contingent earn-out consideration. The company's clinic footprint has expanded, adding a net of 8 clinics year-over-year to reach 779. However, cash reserves have decreased by $10.3 million due to increased investing activities, while the utilization of its revolving credit facility has more than doubled, indicating increased financial leverage.

Filing Stats: 4,495 words · 18 min read · ~15 pages · Grade level 19.1 · Accepted 2025-11-07 16:05:29

Filing Documents

Financial Statements

Financial Statements. 3 Consolidated Balance Sheets as of September 30, 2025, and December 31, 2024 3 Unaudited Consolidated Statements of Net Income for the Three and Nine Months Ended September 30, 2025, and 2024 4 Unaudited Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2025, and 2024 5 Unaudited Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025, and 2024 6 Unaudited Consolidated Statements of Changes in Shareholders' Equity for the Three and Nine Months Ended September 30, 2025, and 2024 7

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 34 Item 3. Quantitative and Qualitative Disclosure About Market Risk 54 Item 4.

Controls and Procedures

Controls and Procedures 54

—OTHER INFORMATION

PART II—OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 55 Item 5. Other Information 55 Item 6. Exhibits 55

Signatures

Signatures 56 2 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION ITEM 1.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS ) September 30 , 2025 December 31, 2024 ASSETS (unaudited) Current assets: Cash and cash equivalents $ 31,102 $ 41,362 Patient accounts receivable, less provision for credit losses of $ 4,263 and $ 3,506 , respectively 67,629 59,040 Accounts receivable - other 23,672 26,626 Other current assets 16,032 10,555 Total current assets 138,435 137,583 Fixed assets: Furniture and equipment 67,522 68,128 Leasehold improvements 58,015 51,105 Fixed assets, gross 125,537 119,233 Less accumulated depreciation and amortization ( 91,315 ) ( 87,093 ) Fixed assets, net 34,222 32,140 Operating lease right-of-use assets 139,926 133,936 Investment in unconsolidated affiliate 12,289 12,190 Goodwill 690,412 667,152 Other identifiable intangible assets, net 176,429 179,311 Other assets 4,557 5,155 Total assets $ 1,196,270 $ 1,167,467 LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTEREST Current liabilities: Accounts payable - trade $ 7,417 $ 5,936 Accrued expenses 56,901 59,513 Current portion of operating lease liabilities 41,960 39,835 Current portion of term loan and notes payable 8,802 10,999 Total current liabilities 115,080 116,283 Notes payable, net of current portion 576 903 Revolving facility 26,500 11,000 Term loan, net of current portion and deferred financing costs 124,384 130,627 Deferred taxes 35,695 29,465 Operating lease liabilities, net of current portion 106,178 101,868 Other long-term liabilities 5,414 18,275 Total liabilities 413,827 408,421 Redeemable non-controlling interest - temporary equity 277,661 269,025 Commitments and Contingencies U.S. Physical Therapy, Inc. ("USPH") shareholders' equity: Preferre

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing